We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Supreme Court Backs Generic Maker in Closely Watched Patent Case
Supreme Court Backs Generic Maker in Closely Watched Patent Case
April 24, 2012
The Supreme Court has unanimously ruled that generic-drug maker Caraco Pharmaceuticals can challenge Novo Nordisk’s “overbroad” patent listing for diabetes drug Prandin, reversing and remanding a lower court’s decision that critics called an existential threat to the generic industry.